Upcoming Events for The Admedus, page-39

What is frustrating as a holder is that despite exposure at a number of events and hitting of key milestones over the last twelve months, the share price is at 60% of the peaks of 18.5c. The market has had enough of the speculation and is demanding hard figures before re-rating. I wish i had of had my cash tied up elsewhere over the past twelve months, but such is the nature of investing in a speculative stock and it is easy to say retrospectively. Should I keep my money in the stock over the next twelve months, I don't know; the figures in the quarterlies should be the deciding factor, in reality. Look forward to results of sales over the coming months and hopefully some sales forecasts from management - will be hard to stay engaged on the basis of milestones being hit only if the share price doesn't move up concurrently.